205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-7.18%
Revenue decline while MRVL shows 7.20% growth. Joel Greenblatt would examine competitive position erosion.
-10.50%
Cost reduction while MRVL shows 7.67% growth. Joel Greenblatt would examine competitive advantage.
-3.63%
Gross profit decline while MRVL shows 6.77% growth. Joel Greenblatt would examine competitive position.
3.83%
Margin expansion while MRVL shows decline. John Neff would investigate competitive advantages.
6.60%
R&D growth above 1.5x MRVL's 3.34%. Michael Burry would check for spending discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.14%
Similar operating expenses growth to MRVL's 2.95%. Walter Schloss would investigate norms.
-5.97%
Total costs reduction while MRVL shows 5.70% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-34.71%
D&A reduction while MRVL shows 0.60% growth. Joel Greenblatt would examine efficiency.
-20.09%
EBITDA decline while MRVL shows 9.28% growth. Joel Greenblatt would examine position.
-13.91%
EBITDA margin decline while MRVL shows 1.94% growth. Joel Greenblatt would examine position.
-11.36%
Operating income decline while MRVL shows 14.12% growth. Joel Greenblatt would examine position.
-4.50%
Operating margin decline while MRVL shows 6.45% growth. Joel Greenblatt would examine position.
-2.00%
Other expenses reduction while MRVL shows 38.98% growth. Joel Greenblatt would examine advantage.
-10.81%
Pre-tax income decline while MRVL shows 15.14% growth. Joel Greenblatt would examine position.
-3.91%
Pre-tax margin decline while MRVL shows 7.40% growth. Joel Greenblatt would examine position.
9.76%
Similar tax expense growth to MRVL's 11.92%. Walter Schloss would investigate patterns.
-10.69%
Net income decline while MRVL shows 15.63% growth. Joel Greenblatt would examine position.
-3.78%
Net margin decline while MRVL shows 7.86% growth. Joel Greenblatt would examine position.
-9.76%
EPS decline while MRVL shows 20.00% growth. Joel Greenblatt would examine position.
-10.00%
Diluted EPS decline while MRVL shows 8.81% growth. Joel Greenblatt would examine position.
-1.18%
Share count reduction while MRVL shows 3.38% change. Joel Greenblatt would examine strategy.
-1.22%
Diluted share reduction while MRVL shows 3.92% change. Joel Greenblatt would examine strategy.